278 related articles for article (PubMed ID: 20833178)
1. A novel method for the detection of antibodies to adalimumab in the presence of drug reveals "hidden" immunogenicity in rheumatoid arthritis patients.
van Schouwenburg PA; Bartelds GM; Hart MH; Aarden L; Wolbink GJ; Wouters D
J Immunol Methods; 2010 Oct; 362(1-2):82-8. PubMed ID: 20833178
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of drug interference in immunogenicity assays.
Hart MH; de Vrieze H; Wouters D; Wolbink GJ; Killestein J; de Groot ER; Aarden LA; Rispens T
J Immunol Methods; 2011 Sep; 372(1-2):196-203. PubMed ID: 21824477
[TBL] [Abstract][Full Text] [Related]
3. Long-term measurement of anti-adalimumab using pH-shift-anti-idiotype antigen binding test shows predictive value and transient antibody formation.
van Schouwenburg PA; Krieckaert CL; Rispens T; Aarden L; Wolbink GJ; Wouters D
Ann Rheum Dis; 2013 Oct; 72(10):1680-6. PubMed ID: 23300118
[TBL] [Abstract][Full Text] [Related]
4. Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisation.
van Schouwenburg PA; van de Stadt LA; de Jong RN; van Buren EE; Kruithof S; de Groot E; Hart M; van Ham SM; Rispens T; Aarden L; Wolbink GJ; Wouters D
Ann Rheum Dis; 2013 Jan; 72(1):104-9. PubMed ID: 22759910
[TBL] [Abstract][Full Text] [Related]
5. Systematic comparison of drug-tolerant assays for anti-drug antibodies in a cohort of adalimumab-treated rheumatoid arthritis patients.
Bloem K; van Leeuwen A; Verbeek G; Nurmohamed MT; Wolbink GJ; van der Kleij D; Rispens T
J Immunol Methods; 2015 Mar; 418():29-38. PubMed ID: 25637408
[TBL] [Abstract][Full Text] [Related]
6. Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis.
Radstake TR; Svenson M; Eijsbouts AM; van den Hoogen FH; Enevold C; van Riel PL; Bendtzen K
Ann Rheum Dis; 2009 Nov; 68(11):1739-45. PubMed ID: 19019895
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to constant domains of therapeutic monoclonal antibodies: anti-hinge antibodies in immunogenicity testing.
Rispens T; de Vrieze H; de Groot E; Wouters D; Stapel S; Wolbink GJ; Aarden LA
J Immunol Methods; 2012 Jan; 375(1-2):93-9. PubMed ID: 21986105
[TBL] [Abstract][Full Text] [Related]
8. A breakthrough novel method to resolve the drug and target interference problem in immunogenicity assays.
Zoghbi J; Xu Y; Grabert R; Theobald V; Richards S
J Immunol Methods; 2015 Nov; 426():62-9. PubMed ID: 26255760
[TBL] [Abstract][Full Text] [Related]
9. Generic anti-drug antibody assay with drug tolerance in serum samples from mice exposed to human antibodies.
Stubenrauch K; Mackeben K; Vogel R; Heinrich J
Anal Biochem; 2012 Nov; 430(2):193-9. PubMed ID: 22935295
[TBL] [Abstract][Full Text] [Related]
10. Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis.
Bartelds GM; Wijbrandts CA; Nurmohamed MT; Stapel S; Lems WF; Aarden L; Dijkmans BA; Tak PP; Wolbink GJ
Ann Rheum Dis; 2007 Jul; 66(7):921-6. PubMed ID: 17301106
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of anti-tumor necrosis factor antibodies-toward improved methods of anti-antibody measurement.
Aarden L; Ruuls SR; Wolbink G
Curr Opin Immunol; 2008 Aug; 20(4):431-5. PubMed ID: 18619538
[TBL] [Abstract][Full Text] [Related]
12. Reprint of "Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab".
Cludts I; Spinelli FR; Morello F; Hockley J; Valesini G; Wadhwa M
Cytokine; 2018 Jan; 101():70-77. PubMed ID: 29174881
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies.
Stubenrauch K; Wessels U; Essig U; Vogel R; Schleypen J
J Pharm Biomed Anal; 2010 Jun; 52(2):249-54. PubMed ID: 20083366
[TBL] [Abstract][Full Text] [Related]
14. Using monoclonal antibodies as an international standard for the measurement of anti-adalimumab antibodies.
van Schouwenburg PA; Kruithof S; Wolbink G; Wouters D; Rispens T
J Pharm Biomed Anal; 2016 Feb; 120():198-201. PubMed ID: 26748377
[TBL] [Abstract][Full Text] [Related]
15. Venous and arterial thromboembolic events in adalimumab-treated patients with antiadalimumab antibodies: a case series and cohort study.
Korswagen LA; Bartelds GM; Krieckaert CL; Turkstra F; Nurmohamed MT; van Schaardenburg D; Wijbrandts CA; Tak PP; Lems WF; Dijkmans BA; van Vugt RM; Wolbink GJ
Arthritis Rheum; 2011 Apr; 63(4):877-83. PubMed ID: 21452312
[TBL] [Abstract][Full Text] [Related]
16. Comparison of long-term clinical outcome with etanercept treatment and adalimumab treatment of rheumatoid arthritis with respect to immunogenicity.
Krieckaert CL; Jamnitski A; Nurmohamed MT; Kostense PJ; Boers M; Wolbink G
Arthritis Rheum; 2012 Dec; 64(12):3850-5. PubMed ID: 22933315
[TBL] [Abstract][Full Text] [Related]
17. A novel homogeneous Biotin-digoxigenin based assay for the detection of human anti-therapeutic antibodies in autoimmune serum.
Qiu ZJ; Ying Y; Fox M; Peng K; Lewin-Koh SC; Coleman D; Good J; Lowe J; Rahman A; Yang J; Jiang J; Quarmby V; Song A
J Immunol Methods; 2010 Oct; 362(1-2):101-11. PubMed ID: 20868690
[TBL] [Abstract][Full Text] [Related]
18. Influence of Immunogenicity on the Efficacy of Long-Term Treatment with TNF α Blockers in Rheumatoid Arthritis and Spondyloarthritis Patients.
Arstikyte I; Kapleryte G; Butrimiene I; Venalis A
Biomed Res Int; 2015; 2015():604872. PubMed ID: 26064930
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a biosensor immunoassay for simultaneous characterization of isotype and binding region of human anti-tocilizumab antibodies with control by surrogate standards.
Stubenrauch K; Wessels U; Vogel R; Schleypen J
Anal Biochem; 2009 Jul; 390(2):189-96. PubMed ID: 19379704
[TBL] [Abstract][Full Text] [Related]
20. Low Percentage of Signal Regulatory Protein α/β
Magill L; Adriani M; Berthou V; Chen K; Gleizes A; Hacein-Bey-Abina S; Hincelin-Mery A; Mariette X; Pallardy M; Spindeldreher S; Szely N; Isenberg DA; Manson JJ; Jury EC; Mauri C
Front Immunol; 2018; 9():2865. PubMed ID: 30568660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
